Literature Citations

Biorbyt Literature Citations (Featured References)

Literature Results (3206)

Construction and characterisation of a functional CD19 specific single chain Fv fragment for immunotherapy of B lineage leukaemia and lymphoma

Publication:Molecular ImmunologyPublished Year:1997Pubmed ID:9566763

Product Name:Anti-CD19 [FMC63]

Product SKU:orb348921

Species:humanApplication:-

Studies of breast cancer imaging with radiolabeled antibodies to carcinoembryonic antigen. Immunomedics Breast Cancer Study Group

Publication:Acta Medica AustriacaPublished Year:1997Pubmed ID:9227788

Product Name:Anti-carcinoembryonic antigen (CEA) [Arcitumomab]

Product SKU:orb348880

Species:-Application:-

Studies of breast cancer imaging with radiolabeled antibodies to carcinoembryonic antigen. Immunomedics Breast Cancer Study Group

Publication:Acta Medica AustriacaPublished Year:1997Pubmed ID:9227788

Product Name:Anti-carcinoembryonic antigen (CEA) [Arcitumomab]

Product SKU:orb348861

Species:-Application:-

A novel and efficient route for the isolation of antibodies that recognise T cell receptor V alpha(s)

Publication:Molecular ImmunologyPublished Year:1996Pubmed ID:8700165

Product Name:Anti-Vα TCR [34]

Product SKU:orb348924

Species:-Application:-

The biologic effects of C225, a chimeric monoclonal antibody to the EGFR, on human prostate carcinoma

Publication:Journal of Immunotherapy with Emphasis on Tumor Immunology: Official Journal of the Society for Biological TherapyPublished Year:1996Pubmed ID:9041461

Product Name:Anti-EGFR [C225 (Cetuximab)]

Product SKU:orb348882

Species:-Application:-

A novel and efficient route for the isolation of antibodies that recognise T cell receptor V alpha(s)

Publication:Molecular ImmunologyPublished Year:1996Pubmed ID:8700165

Product Name:Anti-Vα TCR [34]

Product SKU:orb348858

Species:-Application:-

The biologic effects of C225, a chimeric monoclonal antibody to the EGFR, on human prostate carcinoma

Publication:Journal of Immunotherapy with Emphasis on Tumor Immunology: Official Journal of the Society for Biological TherapyPublished Year:1996Pubmed ID:9041461

Product Name:Anti-EGFR [C225 (Cetuximab)]

Product SKU:orb348862

Species:humanApplication:-

Shedding of the soluble form of CD30 from the Hodgkin-analogous cell line L540 is strongly inhibited by a new CD30-specific antibody (Ki-4)

Publication:International Journal of CancerPublished Year:1995Pubmed ID:7530238

Product Name:Anti-CD30 [Ki-3]

Product SKU:orb348919

Species:-Application:-

Shedding of the soluble form of CD30 from the Hodgkin-analogous cell line L540 is strongly inhibited by a new CD30-specific antibody (Ki-4)

Publication:International Journal of CancerPublished Year:1995Pubmed ID:7530238

Product Name:Anti-CD30 [Ki-3]

Product SKU:orb348925